These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. HTLV-I antibody screening in donated blood and thalassemic patients. Chiewsilp P; Iamsilp W; Hathirat P J Med Assoc Thai; 1993 Oct; 76 Suppl 2():103-5. PubMed ID: 7822977 [TBL] [Abstract][Full Text] [Related]
23. Prevalence of human T cell leukemia virus-I (HTLV-I) antibody among populations living in the Amazon region of Brazil (preliminary report). Nakauchi CM; Linhares AC; Maruyama K; Kanzaki LI; Macedo JE; Azevedo VN; Casseb JS Mem Inst Oswaldo Cruz; 1990; 85(1):29-33. PubMed ID: 2215230 [TBL] [Abstract][Full Text] [Related]
24. Antibody to p40tax protein of human T cell leukemia virus 1 and infectivity. Kashiwagi S; Kajiyama W; Hayashi J; Noguchi A; Nakashima K; Nomura H; Ikematsu H; Sawada T; Kida S; Koide A J Infect Dis; 1990 Mar; 161(3):426-9. PubMed ID: 2313123 [TBL] [Abstract][Full Text] [Related]
25. Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2. Dezzutti CS; Guenthner PC; Daniel S; Utz U; Cabrera T; Marshall JH; Bianco C; Lal RB; Cowan EP Clin Diagn Lab Immunol; 2003 Jul; 10(4):715-7. PubMed ID: 12853410 [TBL] [Abstract][Full Text] [Related]
26. Declining trends in HTLV-I prevalence among blood donors in Japan. Yamaguchi K Intern Med; 2001 Jan; 40(1):1-2. PubMed ID: 11201361 [No Abstract] [Full Text] [Related]
27. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina. Berini CA; Eirin ME; Pando MA; Biglione MM J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of anti-HTLV-1 in physical-checkup individuals and blood donors in Taiwan. Yung CH; Chow MP; Hu HY; Tzeng JL; Wu YS; Lyou JY; Liu WT Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):244-51. PubMed ID: 1342641 [TBL] [Abstract][Full Text] [Related]
29. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013. San Martín H; Balanda M; Vergara N; Valenzuela MA; Cartier L; Ayala S; Ramírez E J Med Virol; 2016 Jun; 88(6):1067-75. PubMed ID: 26538335 [TBL] [Abstract][Full Text] [Related]
30. [Lymphotropic retrovirus in multiple sclerosis]. Nuccetelli F; Assetta M; Di Muzio A; Gambi D Minerva Med; 1989 Apr; 80(4):381-2. PubMed ID: 2725941 [TBL] [Abstract][Full Text] [Related]
31. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City. Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026 [TBL] [Abstract][Full Text] [Related]
32. Human T lymphotropic virus I in Indonesia. Very low seroprevalence in the Jakarta area: antibodies in healthy blood donors and in various nonhematological diseases. Tanggo Y; Gultom SP; Simanjuntak T; Sibuea WH; Matsuzaki H; Yamaguchi K Intervirology; 2000; 43(2):77-9. PubMed ID: 10971124 [TBL] [Abstract][Full Text] [Related]
33. Is seroprevalence of HTLV-I/II among blood donors in India relevant? Kumar H; Gupta PK Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844 [TBL] [Abstract][Full Text] [Related]
34. Human T-lymphotropic virus antibody screening of blood donors: rates of false-positive results and evaluation of a potential donor reentry algorithm. Stramer SL; Notari EP; Zou S; Krysztof DE; Brodsky JP; Tegtmeier GE; Dodd RY Transfusion; 2011 Apr; 51(4):692-701. PubMed ID: 20946198 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. Brennan M; Runganga J; Barbara JA; Contreras M; Tedder RS; Garson JA; Tuke PW; Mortimer PP; McAlpine L; Tosswill JH BMJ; 1993 Nov; 307(6914):1235-9. PubMed ID: 8281054 [TBL] [Abstract][Full Text] [Related]
36. Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. Yodoi J; Uchiyama T Immunol Today; 1992 Oct; 13(10):405-11. PubMed ID: 1418377 [TBL] [Abstract][Full Text] [Related]
37. Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotropic virus type-1. Gonçalves DU; Guedes AC; Proietti AB; Martins ML; Proietti FA; Lambertucci JR; Am J Trop Med Hyg; 2003 May; 68(5):562-5. PubMed ID: 12812346 [TBL] [Abstract][Full Text] [Related]
38. Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II. Lipka JJ; Santiago P; Chan L; Reyes GR; Samuel KP; Blattner WA; Shaw GM; Hanson CV; Sninsky JJ; Foung SK J Infect Dis; 1991 Aug; 164(2):400-3. PubMed ID: 1856487 [TBL] [Abstract][Full Text] [Related]
39. [Serological survey of human T lymphotropic virus type I (HTLV-1) IgG antibody in south region of Xinjiang]. Sun H; Chen G; Du W; Ouyang X; Pang Y; He Y; Zhang J; Zhang Y; Zeng Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):366-8. PubMed ID: 15617250 [TBL] [Abstract][Full Text] [Related]
40. High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: a South American health concern. Biglione MM; Astarloa L; Salomón HE; AIDS Res Hum Retroviruses; 2005 Jan; 21(1):1-4. PubMed ID: 15665638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]